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Abstract 
Cancer survival trend analyses are essential to describe accurately the way medical 
practices impact patients’ survival according to the year of diagnosis. To this end, survival 
models should be able to account simultaneously for non-linear and non-proportional 
effects and for complex interactions between continuous variables. However, in the 
statistical literature, there is no consensus yet on how to build such models that should be 
flexible but still provide smooth estimates of survival. In this article, we tackle this 
challenge by smoothing the complex hypersurface (time since diagnosis, age at diagnosis, 
year of diagnosis, mortality hazard) using a multidimensional penalized spline built from 
the tensor product of the marginal bases of time, age, and year. Considering this penalized 
survival model as a Poisson model, we assess the performance of this approach in 
estimating the net survival with a comprehensive simulation study that reflects simple 
and complex realistic survival trends. The bias was generally small and the root mean 
squared error was good and often similar to that of the true model that generated the data. 
This parametric approach offers many advantages and interesting prospects (such as 
forecasting) that make it an attractive and efficient tool for survival trend analyses. 
 
Keywords: penalized spline, survival model, tensor product, varying coefficient model, 
generalized additive model, cancer net survival trends, multidimensional smoothing, 
interaction, non-linear effect, non-proportional effect 
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1. Introduction 
1.1. Epidemiological issues and modeling problems 
In cancer descriptive epidemiology, one major indicator is the trend in patient survival 
according to the year of cancer diagnosis (yod) and the trend in the corresponding 
mortality hazard. Indeed, these trends show the way advances in medical practices 
(screening campaigns, diagnostic techniques, treatment options, etc.) have changed 
patient survival over the yod. Within this context, the age at diagnosis is a major variable 
because these practices depend strongly on age; actually, elderly cancer patients present 
frequently comorbidities that may prevent the use of aggressive, though efficient, 
treatment.1 Moreover, describing trends according to the time elapsed since diagnosis 
helps a medical interpretation of the analysis results because that course of time 
corresponds to different steps in the disease and treatment outcomes (post-surgical 
mortality during early follow-up, outcome of the first-line treatment during the first year 
after diagnosis, late relapses, etc.) 
 
Hence, a survival model for trend analysis should model the mortality hazard h as function 
of the age at cancer diagnosis, the yod, and the time since cancer diagnosis and answer at 
least three questions (assuming an improvement over the yod in survival for example): i) 
Did mortality decrease gradually over the yod or was the decrease observed only over a 
few yod? Or, in statistical terms, was the effect of the yod on h linear or non-linear? ii) 
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Was the decrease observed whatever the time elapsed since diagnosis or only at specific 
moments (such as at early follow-up because of better post-surgical management)? Or, 
was the effect of the yod on h proportional or non-proportional? iii) Was the decrease 
dependent on patient age at diagnosis? Or, was there an interaction between age and yod? 
These aspects (non-linearity, non-proportionality, and interaction) are very often met in 
real data; for example, in the French cancer survival population-based data,2 the effect of 
age at diagnosis was almost systematically found to be non-linear and non-proportional 
whatever the cancer site. Furthermore, in a study of survival trends in six European 
countries and 15 cancers (90 analyses), Uhry et al.3 found that the effect of the yod was 
non-proportional in 70% of the analyses and that it depended on age at diagnosis in two 
thirds of the analyses. Thus, one key issue in modeling survival trends is to build a flexible 
model able to reflect simultaneously these three fundamental aspects while providing 
smooth estimates. 
  
1.2. What has been used so far for studying net survival trends? 
Up to now, few attempts have been made to build such a flexible model. Indeed, in 
international trend studies4, 5, net survival (NS), the main survival indicator used in the 
context of cancer descriptive epidemiology, is almost exclusively estimated separately 
for each period without modeling and using non-parametric estimators of NS.6, 7 Such 
stratified analyses have well-known limitations: arbitrary choices of period- and age-
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strata, loss of information due to categorization of continuous covariates, imprecision due 
to multiple stratification, possible inconsistencies in NS trends across age strata and 
considerable difficulties in studying covariate interactions. In addition, such analyses only 
provide NS estimates and not a description of the excess mortality hazard (hE) that 
constitutes an additional and essential clinical piece of information.  
Despite the significant progress in flexible parametric modeling,8-13 few studies analyzed 
trends opting for a modeling approach and keeping time, age, and yod as continuous 
covariates14, 15; however in these studies, age-yod or age-yod-time interactions were not 
considered.  
To our present knowledge, only one study has proposed a modeling approach that allows 
for a potentially complex effect of the yod.3 However, in this study, defining and selecting 
the appropriate models were quite challenging and achieving a balance between 
flexibility and parsimony required building nineteen models that differed in modeling the 
effect of the yod in terms of linearity, proportionality and interaction with age; the final 
model was chosen according to the Akaike Information Criterion. This study highlights 
the difficulty of achieving a flexible modeling of hE(t,a,y) through a classical model-
building strategy (guiding principles were proposed without reaching consensus11); the 
number of candidate models may be very large, which requires sound choices for model 
specification, choices that become more difficult as the study-period or follow-up 
lengthens. Moreover, variance is under-estimated if the selection process is not accounted 
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for and there is no simple solution for taking this phenomenon into account in the 
statistical inference; a correct variance estimation requires heavy bootstrap techniques or 
to consider multi-model inference.16 
 
1.3.  A flexible modeling for survival trend analyses: the MPS approach  
To tackle the challenge of modeling of hE(t,a,y) in a flexible and convenient way, we 
propose to consider the issue as a problem of modeling a complex hypersurface hE(t,a,y) 
and to smooth this surface using a multidimensional penalized spline (MPS). The MPS 
approach is a powerful tool originally developed for Generalized Linear Models.17 We 
adapted it to the survival context. One of the major benefits of this solution is that it 
reduces the model-building issue evoked above. The objective of the present paper is to 
evaluate the performance of this adapted MPS approach for usual studies of trends in net 
survival and excess mortality hazards, using realistic simulations. The proposed approach 
focuses herein on NS but is obviously suitable for overall survival too. 
 
The present article is organized as follows: after a brief review of the NS concept, section 
2 presents the proposed approach, highlighting the relationship between the MPS and the 
varying-coefficient model.18 A comprehensive simulation study is carried out based on 
real data to assess the performance of this approach regarding its ability to fit various NS 
trends; section 3 presents the design, the theoretical parameters, and the indicators of 
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performance. Section 4 presents the results of these simulations and section 5 a general 
discussion. In the online supplementary material, we present an analysis of real data (from 
the French cancer registries) with the R-code necessary to reproduce this analysis (this 
code is available on the GitHub repository 
https://github.com/RocheLHCL/SMMR_Remontet2018 ). 
 
2. Multidimensional penalized splines for a (net) survival model 
2.1. Introduction to the concepts of excess mortality hazard model and net survival 
In the competing-risk context of cancer survival, individuals may die from cancer or from 
another cause but, in cancer registries, the causes of death are not always available or 
reliable. In addition, cancer treatments may have long-term toxicities and ultimately cause 
death; these extra-deaths are then “due to cancer”. These two reasons make “excess 
mortality” a relevant concept. This excess mortality can be estimated by supposing that, 
in cancer patients, the mortality due to others causes than the cancer can be obtained from 
the (all causes) mortality of the general population; the latter is referred to as the 
“expected mortality” hP. Then, the mortality observed in cancer patients (hO) may be 
written as: 
ℎ,  = ℎ	, , 
 + ℎ + ,  (1) 
In this equation, hE is the excess mortality hazard due to cancer, t is the time elapsed since 
cancer diagnosis, a is the age at cancer diagnosis, hP is the mortality of the general 
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population at age a+t given demographic characteristics z (hP is considered known and 
available from national statistics), x is a vector of variables that may have an effect on hE, 
and β is the vector of parameters of interest to be estimated. 
Fully parametric models8-10 have been proposed to model hE e.g., log[hE(t,x,β)] = f(t) + 
g(x) + h(t)x where f, g, and h are flexible functions such as cubic splines. 
Let us consider an observation ti, δi, xi, and zi of subject i, with δi=1 when ti corresponds 
to the time of death and δi=0 when ti corresponds to a censored observation, the 
contribution of that observation to the log-likelihood may be written (up to a constant): 
 = − ℎ	, ,


 +	 ℎ	,  ,  + ℎ + , !" 
 
In a non-penalized framework, the maximum likelihood method may be used to estimate 
parameters β of the excess hazard model.8, 10, 19 However, specific numerical techniques 
are necessary to approximate the integral involved in the likelihood. In 2007, Remontet 
et al.10 showed that using the ‘point-milieu’ approximation for the integral leads to a 
likelihood similar to the one obtained with a Poisson model on split data (a model that 
uses a modified link function so as to incorporate the expected mortality rates). Taking 
advantage of this similarity, a survival model can then be fitted in a numerically practical 
manner by using a Poisson regression; herein, this approach will be referred to as “Poisson 
approach”. 
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Finally, once parameters β are estimated, NS, the survival that would be observed if 
cancer was the only cause of death, can be directly obtained from hE using the classical 
relationship between hazard and survival: #$,  = %& '−( ℎ	, ,	 ) 
 
2.2. Introduction to the multidimensional penalized spline approach 
The general principle of penalized splines consists in modeling the parameter of interest 
(here, hE) as a function of a vector of variables (here, time since diagnosis, age at 
diagnosis, and yod) using highly flexible functions. This flexibility is typically obtained 
with splines with a number of knots higher than what is deemed necessary (this leads to 
a high number of parameters). In the classical unpenalized likelihood framework, such 
flexibility leads to a high variability of the estimators and to an overfitting. In the 
penalized spline framework, these drawbacks are overcome by considering a penalized 
likelihood as the objective function obtained by adding to the classical likelihood a term 
that penalizes “wiggly” functions. One common choice among the penalization terms is 
the integral of the squared second derivative of the fitted function: this choice penalizes 
the functions that are too wiggly, achieves smoothness, and prevents from erratic 
estimation. The trade-off between model fit and model smoothness is controlled by a 
smoothing parameter λ. 
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The very clear and instructional article by Wood20 presents the essentials for 
understanding and using penalized splines; specifically, building the penalization term, 
optimizing the penalized likelihood (with estimation of λ), and making statistical 
inference with examples that use mgcv package17 in R (see also Marra and Radice21 and 
Eilers and Marx22). Another useful and instructional reference is a more general overview 
by Ruppert et al.23 that presents a mixed-model representation of penalized splines and 
Bayesian models with longitudinal and spatial effects. 
 
The multidimensional version of penalized splines, based on tensor product of basis 
functions, has been already proposed in Generalized Linear Models by Wood24 and by 
Marx and Eilers.25, 26 An interesting example of the use of these MPSs in a Poisson model 
was given by Ugarte et al.27 who modeled the number of deaths from prostate cancer as 
a function of the year of death and the geographic coordinates (longitude and latitude) of 
the residential area (see also Etxeberria et al.28). The tensor product of these three 
variables constitutes a spatio-temporal model and, together with Currie et al.29, Ugarte 
proposes to use it as a projection tool. 
 
2.3 Multidimensional penalized splines in (net) survival models 
2.3.1. Modelling the mortality hazard with a varying coefficient model 
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To model log [hE(t,a,y)] as a function of time since diagnosis t, age at diagnosis a, and 
yod y, we propose using a MPS whose basis is built by the tensor product of three 
marginal bases chosen for t, a, and y. To motivate this choice, we show its relationship 
with the varying coefficient model.18 
 
First, let (mi(t))1≤i≤I, (qj(a))1≤j≤J, and (bk(y))1≤k≤K be three low-rank bases for smooth 
functions ft, fa, and fy, respectively: 
* =+,-;	
/
01
	*2 =+34
5
401
64;	*78 = +9:98
;
901
 
where µi, θj, and βk are the parameters to estimate. 
 
For a clear illustration, let us take a very simple (though unrealistic) example, starting 
from a basic model in which the dynamics of the hazard according to time is log-linear: 
 ℎ	" = * = ,1 + ,< 
 
We now want to take age into account in this model, knowing that this dynamics may 
vary with age. One way of achieving this is to allow the intercept and slope of ft(t) to 
change with age using another basis for age, say a quadratic polynomial 
fa(a)=θ1+θ2a+θ3a2. This gives the following model: 
 ℎ	, " = *2,  = 311 + 31< + 31=< + 3<1 + 3<< + 3<=< 
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In this model, for a given age, log [hE(t|a)] is linear in time and for a given time, log 
[hE(a|t)] is quadratic in age. This six-parameter model can be seen as a varying coefficient 
model where the coefficients of time (intercept µ1=θ11+θ12a+θ13a2 and slope 
µ2=θ21+θ22a+θ23a2) are allowed to change smoothly with age, the “effect modifier”.18 
This change occurs in a structured fashion, in the sense that each age has its own intercept 
and its own slope but two adjacent ages have close intercepts and close slopes. Here, we 
may assume that, symmetrically, time changes the effect of age: the model then obtained 
will be the same. 
 
Going back to the general and the most realistic case, the multidimensional function fta 
will correspond to: 
 ℎ	, " = *2,  = ++3464-
5
401
/
01
 
The construction of the multidimensional function may continue according to the same 
principle but with changes made now to coefficients θij according to y. This leads to: 
 ℎ	, , 8" = *27, , 8 =
∑ ∑ ∑ 49:9864-;9015401/01
 
(2) 
that is, the multidimensional basis consists of the K×J×I terms bk(y)×qj(a)×mi(t) obtained 
by the product of the terms of the marginal basis. This basis construction is rather simple 
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and may be extended to any number of variables. It is essential to see from (2) that this 
model allows simultaneously for non-linearity and various interaction patterns. In 
particular, i) qj(a)×mi(t) and bk(y)×mi(t) terms allow for non-proportional effects of age 
and yod, respectively; ii) bk(y)×qj(a) allows for complex second-order interactions 
between age and yod; iii) bk(y)×qj(a)×mi(t) allows for complex third-order interactions 
between yod, age, and time. However, in (2), there are K×J×I terms to estimate; a 
penalization is thus required to avoid wiggly surfaces. 
 
2.3.2. Measure of function wiggliness and penalized likelihood 
The measure of wiggliness of a multidimensional function ftay to use for penalization is 
based on the second derivatives and is detailed in the publication of Wood.24  
Adding this penalization term to the likelihood leads to an excess mortality hazard hE that 
varies smoothly with t, a, and y; thus, the change in hazard between adjacent times, 
adjacent ages, or adjacent yod cannot be rough. This smoothing is very appealing and 
natural in the context of cancer survival trends where it is not expected that treatment 
improvements would lead to sudden changes in mortality between close years or close 
ages. 
 
2.3.3. Choice of the marginal bases used for the mortality hazard  
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To represent functions ft, fa, and fy, we opted for restricted (or “natural”) cubic splines as 
low-rank bases; the dimensions of these bases depend thus on the number of knots chosen. 
In the penalized framework, the basis dimension should be set to a value slightly higher 
than that deemed necessary, which brings flexibility. Here, we will focus on net survival 
trend analyses over 20 yod with 5 years of follow-up (see the details in section 3). 
According to our experience in cancer survival analysis and the recommendations of 
Herndon and Harrell,30, 31 we have chosen to use six knots (including boundary knots) to 
model ft, the dynamics of hazard (6 parameters), five knots to model fa (the effect of age 
at diagnosis), and four knots to model fy (the effect of the yod). Given the number of 
knots, 120 parameters have to be estimated in Formula 2. 
According to Gray32 and Herndon and Harrell,31 knot location may be based on the 
empirical percentiles observed in the population of patients who died, which yields in our 
case, considering the number of knot we have chosen: i) 0th, 20th, 40th, 60th, 80th, and 100th 
percentiles of survival time for ft; ii) 0th, 25th, 50th, 75th, and 100th percentiles of age at 
diagnosis for fa; and, iii) 0th, 33th, 66th, 100th percentiles of yod for fy. 
 
 
2.3.4. Parameter estimation and practical implementation in survival models 
Survival models with penalized splines face the same integration problem as models with 
non-penalized splines (see section 2.1). Previous works have addressed this issue for 
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unidimensional penalized splines: in 2013, Rodriguez et al.,33 used a penalized Poisson 
approach to fit a penalized survival model (an approach that parallels that of Remontet et 
al.10 in the unpenalized framework). This approach allows benefiting from the well-
known Generalized Additive Model (GAM) framework.17, 34, 35 In 2005, Kauerman36 and 
Becher et al.37 considered also a penalized survival model as a Poisson GAM model using 
trapezoid techniques to approximate the integrals. In 2016, Liu et al.38 proposed a 
penalized generalized survival model based on the parametric Royston-Parmar 
approach.39 The latter authors modeled directly the cumulative hazard, which avoids the 
difficult integration and replaces it by a simple derivation. 
 
Here, we adopted the Poisson approach described by Rodriguez to implement the MPS 
in the excess hazard model. To this end, we split the original data into small intervals (as 
described by Remontet et al.10) and, being in the context of the excess hazard model, 
changed the link function of the Poisson model to allow for the population mortality 
hazard hP.19 In practice, using version 1.8-3 of mgcv, model (1) with tensor product (2) 
has been implemented on split data using function te() to build the tensor product basis 
and using gam function to fit the model. Function gam makes it possible to adjust the 
penalized Poisson model and use a personalized link function. The model was fitted using 
a P-IRLS algorithm and the smoothing parameters λt, λa, and λy were estimated by 
Restricted Maximum Likelihood (REML).17  
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2.3.5. Derivation of the net survival and the confidence intervals 
Once the parameters of the model are estimated as detailed above, the net survival at 
given time since diagnosis, age at diagnosis, and yod is obtained by integration of the 
excess mortality hazard using Gauss-Legendre quadrature. Using the delta-method and 
assuming normality of the logs of the cumulative hazards, the confidence intervals of the 
net survival (age-specific or age-standardized) are obtained from the Bayesian posterior 
covariance matrix (Vp in package mgcv) of the 120 parameters.17, 40  
 
 
3. The simulation study 
To assess the performance of this MPS approach in net survival trend analysis, we 
simulated survival data under 5 scenarios that represent a variety of trends seen in real 
data analyses. 
 
3.1. The simulation design 
Type of models used for the scenarios 
The five scenarios represent gradually complex trends; we chose then five cancers sites 
according to the results of SUDCAN study for France3 (esophagus, stomach, breast, 
cervix uteri, and ovary). For each cancer site, we adjusted a flexible parametric excess 
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hazard model on the French survival data.41 The model mimics the effects found in 
SUDCAN (see details in Supplementary table S1). The scenarios differ in the effect of 
the yod that could be linear or non-linear, proportional or non-proportional, age-
dependent or age-independent, and the most complex scenarios included third-order 
interactions (table S1). However, the adjusted model used fractional polynomials11 
instead of splines because splines are the basis functions of the tensor; thus, using the 
same bases for data generation and analyses would overestimate the performance of the 
MPS approach. Practically, to choose the powers of the fractional polynomials, we 
adapted the model-building strategy proposed by Sauerbrei et al.12 Finally, for each 
scenario, the parameters obtained were regarded as theoretical parameters and used to 
generate the data. 
 
Sample characteristics  
Two sample sizes were considered for each scenario (N=2,000 and N=10,000). In the 
settings with 2,000 patients, we simulated M=1,000 datasets whereas in the settings with 
10,000 patients, we simulated only M=200 datasets to limit the computing time. In each 
scenario, we simulated a cohort with a similar age-distribution as observed in the French 
data used to obtain the theoretical parameters. The yod was randomly sampled from a 
uniform distribution between 1990 and 2010. Patients were censored at 5 years or at end 
of follow-up in 2013.  
18 
 
 
Generation of time to death T 
For each individual, the time to death T was the minimum of the time to death due to 
cancer (TE) and the time to death from other causes (TP), each being generated separately 
according to the age and the yod of the individual. TP was generated using a piecewise 
exponential distribution as described by Danieli et al.42 TE was generated using the inverse 
transform approach described by Crowther and Lambert43 for the survival context. The 
cumulative distribution F@t	of TE, which is derived from the parametric expression of 
hE as F@t = 1 − exp	F−( h@vdvJ K, is then numerically inverted to generate TE from 
a uniform distribution; i.e., L	 = F@M1u where u is drawn from a uniform distribution. 
 
3.2. Description of the theoretical trends of each scenario 
Theoretical excess mortality hazards for 3 ages, 3 years, and each scenario are shown in 
Figure 1. The theoretical trends of NS by age can be seen in Supplementary Figure S7 for 
example (solid line). 
Scenario 1 used data on esophagus cancer and assumed no effect of the yod to allow 
assessment of the performance of the MPS approach in a context where the smoothing of 
the yod effect must be important. Another interesting feature of this scenario is the non-
monotony of the hazard function according to the time elapsed since diagnosis: the excess 
mortality hazard increased up to one year after diagnosis then decreased dramatically 
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(Figure 1). This means that the smoothing of the effect of time should not be too important 
to correctly reproduce this curvature. 
Scenario 2 used data on stomach cancer and considered that the effect of the yod was non-
linear, non-proportional, and had no interaction with age at diagnosis. In this scenario, 
the strengths of these non-linearity and non-proportionality are rather low. 
Scenario 3 used breast cancer data and considered that the effect of the yod was non-
linear, proportional, and had an interaction with age at diagnosis. In this scenario, the net 
survival increased with the yod whatever the age but the magnitude of the increase 
depended on age (Figure S7). In addition, unlike the two previous scenarios, the 
theoretical excess mortality hazard was moderate and relatively constant along the time 
elapsed since diagnosis (Figure 1). 
Scenario 4 used cervical cancer data. This cancer showed a linear and non-proportional 
effect of the yod, with a strong age-yod interaction and a triple interaction between time, 
age, and yod. In young women, at fixed time points since diagnosis between 0 and 24 
months, the excess mortality decreased with the yod. In contrast, in elderly women, the 
excess mortality increased with the yod whatever the position of this time since diagnosis 
(Figure 1). This leads to an interesting feature in NS trends because NS improves in young 
patients but worsens in the elderly (Figure S7). All these hazard variations of cervical 
cancer are shown in Figure S1 that presents the theoretical excess mortality hazards in 
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3D-plots. This figure illustrates the complexity of the hypersurface we attempt to model 
with MPS.  
Scenario 5, the most complex one, used ovarian cancer data and included a non-linear 
and non-proportional effect of yod together with a triple interaction. Indeed, at 
intermediate ages and fixed times since diagnosis less than 3 years, the excess mortality 
hazard decreased with the yod, whereas it increased with the yod for greater time spans. 
However, this reverse trend was less marked in young or old ages, which explains the 
need for a triple interaction. 
 
Figure 2 shows the theoretical 1- and 5-year standardized net survival (sNS) according to 
the yod in each of the five scenarios (black solid curve). In Scenario 2 (stomach cancer), 
the curve shows an atypical pattern during the first yod; the sNS in 1990 is slightly higher 
than the one in 1991 while the survival increases afterwards (this atypical pattern is due 
to the use of a fractional polynomial for the effect of the yod with powers equal to 2 and 
-2, see Table S1). In Scenario 3 (breast cancer), the 5-year sNS curve starts flattening in 
year 2007. In Scenario 5 (ovary cancer), the flat part occurs between 1990 and 1995. 
 
3.3 Simulated data analysis 
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Simulated data were analyzed using a tri-dimensional MPS in which the bases, the 
number and positions of knots, the parameter estimation method, and the practical 
implementation are described in sections 2.3.3 and 2.3.4. 
 
Furthermore, in order to have comparative elements to assess the performance of the 
MPS, we also analyzed the data with two alternative models:  
i) the true model (i.e., the model that generated the data) that can be considered as a “gold-
standard”, and which also enables us to validate our data generation algorithm, 
ii) a basic “PH model” that may be written:  ℎ	, , 8" = * + *2 + *78, 
where functions f are defined as in the above MPS approach; i.e., restricted cubic splines 
with same number and positions of knots as in the MPS approach (except that the intercept 
is dropped for fa and fy for identifiability purposes). This PH model had 13 parameters 
and allowed for non-linear but proportional effects without interactions.  
 
In the true and the PH model, the maximum likelihood parameter estimates (without 
penalization) were obtained with a homemade procedure based on Cavalieri-Simpson 
integral approximation and a Newton-Raphson algorithm.10 
 
3.4. Assessment of the performance of the MPS approach 
22 
 
We examined the performance of the MPS approach and of the two alternatives in 
estimating the age-standardized net survival for a given yod (denoted sNS(y)): this 
parameter of interest was calculated in two steps using a refined annual age 
standardization as described by Uhry et al.3 First, NS for each 5-year age-classes was 
calculated by averaging the NS predicted from the model for each annual age, using 
within-age-class weights as observed over the whole data. This way, the age structure 
within age-classes is fixed and does not vary with the year of diagnosis. The age-
standardized NS was then derived from these age-class estimates using the ICSS 5-years 
weights.44 
For each of the ten settings considered (5 scenarios × 2 sample sizes) and over the M 
simulated datasets (M=1,000 or 200, see section 3.1), we estimated: i) the bias, defined 
as the difference between the average of the M estimated values and the theoretical value 
of the parameter of interest; ii) the Root Mean Squared Error (RMSE), defined as the 
square root of the average of the squared differences between the M estimated values and 
the theoretical value; iii) the empirical coverage probability (CP), defined as the 
proportion of 95% confidence intervals that include the theoretical value.  
 
 
4. The simulation study results 
4.1. Bias, RMSE, and coverage probabilities 
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Figure 2 shows the mean (over 200 simulated datasets with 10,000 patients) of the sNS 
estimates obtained with the MPS approach and the PH model (see also Figure S2 for 
sample size 2,000 patients). Figure 3 shows for each scenario the bias made in estimating 
the 1- and 5-year sNS according to the yod, the method (true model, MPS, or PH model) 
and the dataset size (2,000 or 10,000 patients). As expected, the bias is null with the true 
model. With the PH model, the bias is generally greater than with MPS and does not 
decrease when the sample size increases. With MPS, the bias is generally low (-1 to +1) 
and lower with 10,000 than with 2,000 patients. Nevertheless, a bias of nearly -2 was seen 
with stomach cancer data of 1990 whatever the sample size; this shows that the MPS did 
not reproduce the atypical pattern of 1990. The MPS did not reproduce the flat trend 
observed in ovary and in breast cancers but led to only a slight bias in sNS with 10,000 
patients. In section 4.2, we will focus on two noticeable behaviors of the MPS: i) a small 
bias at 1 year observed with esophagus data (N=2,000) ii) the absence of bias with 
cervical data despite highly complex trends. 
 
Figure 4 shows the RMSEs according to the yod (same panel order as in Figure 3). In all 
five scenarios, the RMSE of the PH model was much higher than that of the true model 
or the MPS. In the simplest Scenario 1 (esophagus cancer, no effect of the yod), the true 
model had a lower RMSE than MPS. However, in all other scenarios and settings, the 
MPS and the true model had very close RMSEs. With stomach (at 5 years after diagnosis 
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in yod 1990) and breast data (at 5 years in 2010), the RMSE of MPS was very close to 
that of the true model despite the biases seen in Figure 3. Thus, MPS returned slightly 
biased but less variable estimates than those of the true model. On the basis of the results 
shown in Figure 4, Table 1 classifies the methods according to the RMSEs of the 
estimators of sNS at 5 year after diagnosis. This table shows that the performance 
indicators of MPS are identical to those of the true model, except in the simplest Scenario 
1, and always better than those of the PH model, especially with the large sample size 
10,000. 
 
Figure 5 shows the coverage probabilities according to the yod (same panel presentation 
as in Figures 3 and 4). We should recall first that these probabilities are estimated with 
1,000 and 200 simulated datasets when the sample size is, respectively, equal to 2,000 
and 10,000 patients. So, to check whether MPS provides coverage probabilities close to 
the nominal value of 95%, it is better to focus on cases with 2,000 patients, those for 
which the accuracy of the estimation is the highest. Figure 5 shows then that the coverage 
probabilities of MPS are generally very satisfactory, though they are unsurprisingly lower 
than 95% in case of bias (e.g., stomach or ovary data of 1990) and higher than 95% in 
one case (breast around yod 1997). 
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In the online supplement, additional results are presented to detail the performance of the 
MPS approach and of the PH. Figures S3 to S6 show the theoretical hE(t) for 3 ages and 
3 years and the mean of the estimate obtained with the two methods and two samples 
sizes. In the same spirit, Figures S7 to S10 show the theoretical trends of NS(t=1) and 
NS(t=5) by age and the mean of the estimates. 
 
 
4.2. Focus on two behaviors of the MPS approach 
 
The 1st focus point concerns the +0.5 bias seen with MPS at one year after diagnosis with 
esophagus data and 2,000 patients (Figure 3). Figure S3 shows that, at the beginning of 
the follow-up, the theoretical high curvature seen in young patients is too smoothed by 
the MPS: the estimated hazards are too small and the estimated NS too high, which leads 
to a small positive bias in young patients (Figure S7) and to an overall bias of +0.5. 
However, with 10,000 patients, this oversmoothing disappears practically and the fit 
becomes adequate (Figures S4 and S8). 
 
The 2nd focus point concerns the good adjustment made with MPS in the cervical cancer 
scenario. The strong interaction between age and yod that leads to opposite trends in 
function of age is perfectly rendered by the MPS approach (Figure S7 and S8). On the 
26 
 
contrary, the PH model leads to a poor fit to the data; this is shown in Figures S5 and S6 
in terms of hazard and Figures S9 and S10 in terms of NS. For example, in patients aged 
79 years at diagnosis and at five years after diagnosis, the bias with the PH model is -6 in 
1990 and +4 in 2010 whatever the sample size (Figures S9 and S10). 
Lastly, a practical illustration of the MPS and PH approaches is presented in the last 
section of the online supplement, using real data from 5977 cervical cancer cases (the 
dataset used to determine the theoretical parameters in the cervix uteri scenario). 
 
 
5. Discussion 
5.1. Main finding: the good performance of the MPS approach 
In this work, we propose a MPS modeling to describe the changes in cancer excess 
mortality in function of time since diagnosis, age at diagnosis, and yod and explore thus 
the trends of net survival. The excess mortality hazard hE(t,a,y) is modeled through a 
tensor product of the marginal basis of the three variables. This approach allowed a 
simultaneous modeling of non-linear effects and all types of interaction between variables 
(including non-proportionality). The work adapted the statistical framework developed 
by Wood for Generalized Linear Models17 to the survival and net survival contexts. The 
extensive simulation study performed here showed that the performance indicators of the 
MPS approach are close to those of the true model (except in a scenario where there is no 
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effect of the yod). One major strength of this result is that it was obtained through the 
analysis of realistic simulated data generated from a model that used fractional 
polynomials and thus that cannot be considered as a submodel of the MPS under 
evaluation. 
 
The simulation study explored five realistic scenarios that allow for some complexity in 
terms of effects or interaction(s). We noted a lack of fit of the MPS in two situations. The 
first is that of esophagus cancer where the hazard shows an important curvature: with a 
small sample size --thus a weak signal-- the MPS smoothing was too important and the 
curvature could not be fully fitted, which generated a slight but systematic bias. However, 
this bias faded with a larger sample size. This case illustrates the bias induced by 
penalization: when the information is insufficient, the MPS tends to oversmooth the 
curves and show simpler effects than the theoretical ones. The second situation happens 
when changes in sNS occurred at the beginning or at the end of the diagnosis period which 
led, respectively, to bias in 5-year SNS in stomach cancer in 1990 and in breast cancer in 
2010. However, smoothing may provide more stable estimates and, in both situations, 
despite the bias, the RMSE of the MPS was equivalent to that of the true model.  
In summary, the MPS has shown its ability to fit simple as well as complex trends (as in 
ovary and cervical cancers whose trends depend on age). 
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5.2. Computing aspects, smoothing parameter estimation, basis function, and type 
of penalties 
In the present work, the practical implementation of the MPS was greatly simplified by 
the recourse to the Poisson approach and to the powerful package mgcv. Actually, after 
data splitting, the adjustment was made within a Poisson model that had a setting-specific 
link function. Package mgcv (especially function gam) is remarkably stable: over 6,000 
simulated dataset runs (5,000 runs on 2,000 patients and 1,000 runs on 10,000 patients), 
only one failed to converge (Scenario 3 with 2,000 patients). Furthermore, function gam 
is relatively fast: with a dataset on 10,000 patients (that is, a split dataset with nearly 
200,000 lines), the model fitting took nearly 3 minutes on a single desktop computer with 
Intel i7-4790 3.60 GHz and 16 GB of RAM. Despite the computing efficiency of package 
mgcv, the algorithms used in GAM were demanding in the survival context. Indeed, the 
Poisson approach requires data augmentation and the number of parameters to estimate 
is important due to the tensor product of three dimensions (here, 6×5×4=120 parameters). 
These two aspects imply dealing with huge matrices that require large RAMs. For 
example, above 1,500,000 lines (about 70,000 patients), the analysis failed due to lack of 
memory. 
Generalized Cross-Validation (GCV) and REML can be used to estimate the smoothing 
parameters. When the Bayesian covariance matrix is used, additional simulations showed 
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that the results obtained with REML and GCV were almost identical in terms of bias, 
RMSE, and coverage probability (data not shown): in the present context, both methods 
are good solutions to estimate the smoothing parameters.  
In this work, knot location was based on the quantiles of variables of patients who died, 
which is a common choice in survival analyses.9, 30, 31 Restricted cubic splines were used 
as basis functions for time since diagnosis, age, and yod; they are implemented in package 
mgcv via options bs=’cr’ of the te function. The P-splines proposed by Marx and Eilers22, 
25, 26 are also implemented in te function (option bs=”ps”). In the P-spline approach, the 
basis functions are cubic B-splines, the knots should be evenly spaced, and the 
penalization is directly imposed on the coefficients. Additional results suggested that, in 
our setting, performances of the P-spline tensor and MPS were roughly comparable. Other 
choices concerning the bases are theoretically possible with function te but the user should 
then build his/her own bases (see function smooth.construct of package mgcv). 
 
 
5.3. Interest and limits of the present approach, applicability in case of small sample 
size 
The simulation results support the fact that the MPS approach is well-adapted to 
descriptive cancer epidemiology, especially to the analysis of the trends of net survival 
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as well as, naturally, the trends of “overall” survival (which may be simply obtained by 
setting the population mortality hazard hP to zero). 
 
The main objective was to build a flexible model able to provide smooth estimates at the 
same time. This objective was achieved with the MPS: the tensor product of cubic 
regression splines provides flexibility, including high-order interaction, while the 
smoothing parameters provide smoothness in each of the three directions (t,a,y). 
 
Another asset of the MPS is the simultaneous specification of non-linearity, non-
proportionality, and other interactions, which is directly obtained by modeling 
hypersurface (t,a,y,h(t,a,y)). This simultaneous specification is essential in survival 
analysis because non-linearity and non-proportionality do interact: omitting or 
misspecifying the functional form of a continuous variable may lead to spurious non-
proportionality and, conversely, omitting or misspecifying non-proportionality may lead 
to a spurious functional form.45, 46 When the number of variables is low, the very 
challenging issue of model-building strategy can then be reduced with MPS. 
 
The parametric aspect of MPS allows explicit derivations of hazard, survival functions, 
and predictions. This allows a large choice of graphical displays of the results (examples 
can be found in Supplementary data). In particular, the dynamics of the mortality hazard 
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is valuable for clinicians and epidemiologists. Moreover, predictions can be made for any 
variable value, which allows: i) deriving other interesting outcomes such as the crude 
probability of death47 or the number of years of life lost due to cancer;48 ii) performing 
fine standardization, which avoids residual age effects that may affect the classical 
standardization3, iii) using MPS as a forecasting tool. 
 
In the MPS framework, the three variables (time since diagnosis, age at diagnosis, and 
yod) are kept in their original continuous form, which prevents a loss of information that 
occurs inevitably upon variable categorization and allows an accurate description of 
variable effects. One may note that these three variables are dealt with equally; i.e., in 
specifying the model, variable t has no particular mathematical role (contrarily to what is 
generally seen in survival models). 
 
To provide practical guidelines for practitioners in case of small sample sizes, we checked 
the behavior of the MPS approach by running additional simulations on 250 to 1,000 
cases in the ovarian cancer scenario (data not shown). The MPS worked satisfactorily 
with no convergence problems and provided better RMSE values than with the true model 
or the PH model. Thus, given its favorable bias-variance trade-off with small sample 
sizes, the MPS approach seemed to be robust and efficient. However, as in any other 
statistical analysis, the amount of information needed to study a phenomenon depends on 
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the magnitude of this phenomenon; in the ovarian cancer example, N=1000 was the 
minimum necessary to reach a reasonable precision of NS estimates to allow studying 
their trends. 
 
The present method reaches its limit when the number of variables increases. For 
example, dealing with 10 variables having each a marginal basis with four parameters 
leads to estimate 410 parameters, which requires the use of other approaches. In the 
presence of a high number of variables, the penalized likelihood approach can still be 
used but requires further variable selection strategies: Marra and Wood49 gave an 
overview of this subject in GAM (not in survival model) and Rodriguez-Girondo et al.33 
evaluated some of these strategies within the context of survival model but without 
dealing with the presence of interaction between continuous variables. One may cite other 
approaches in survival but these are based on unpenalized likelihood: Sauerbrei et al.12 
proposed a complex algorithm stemming from fractional polynomials and, in a simulation 
study, Wynant and Abrahamowicz6 evaluated four strategies based on a stepwise 
procedure. However, none of these two works dealt with the issue of interaction and the 
procedures became very complex when the number of variables increased. Another 
strategy is the Hazard Regression (HARE) proposed by Kooperberg et al.50 
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5.4. Prospects 
Adding one or two other dimensions to the present MPS approach is an interesting 
prospect. Adding a spatial dimension (as in the work of Ugarte et al.27) would lead to a 
spatio-temporal model whereas adding a deprivation dimension51 would allow analyzing 
survival trends according to the socio-economic status. Furthermore, forecasting being a 
logical consequence of smoothing29 and survival projections being an important public 
health topic, it would be interesting to use the MPS as a projection tool. 
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Table 1 - Comparison of model performance according to the RMSEs of the estimators 
of the standardized 5-years net survival. 
Scenario Sample size Rank 
Esophagus 2,000; 10,000 True model > MPS > PH model 
Stomach, breast, cervix uteri, ovary 2,000 MPS ~ True model > PH model 
Stomach, breast, cervix uteri, ovary 10,000 MPS ~ True model >> PH model 
“~” equivalent to, “>” more performant than, “>>” much more performant than 
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Legends to the figures 
 
Figure 1. Theoretical excess mortality hazard as a function of time since diagnosis in the 
five scenarios, at 3 ages (10th, 50th, and 90th percentiles of the age distribution of the 
cases). Black solid curve: year of diagnosis 1990; red dashed curve: year of diagnosis 
2000; green double-dashed curve: year of diagnosis 2010 
 
Figure 2. Standardized 1 and 5-years net survival as a function of the yod in the five 
scenarios with 10,000 patients. Black solid curve: theoretical net survival trends. Red 
dashed curve: mean of the standardized net survival estimated using MPS. Blue double-
dashed curve: mean of the standardized net survival estimated using the PH model. 
 
Figure 3. Bias in estimating the standardized 1 and 5-years net survival as a function of 
the yod in the five scenarios with 2,000 and 10,000 patients. Black solid curve: bias with 
the true model. Red dashed curve: bias with the MPS. Blue double-dashed curve: bias 
with the PH model. 
 
Figure 4. Root Mean Squared Errors in estimating the standardized 1 and 5-years net 
survival as a function of the yod in the five scenarios with 2,000 and 10,000 patients. 
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Black solid curve: RMSE with the true model. Red dashed curve: RMSE with the MPS. 
Blue double-dashed curve: RMSE with the PH model. 
 
Figure 5. Coverage probability (CP) of the 95% confidence intervals of the estimates of 
the standardized 1 and 5-years net survival as a function of the yod in the five scenarios 
with 2,000 and 10,000 patients. Black solid curve: CP with the true model. Red dashed 
curve: CP with the MPS. Blue double-dashed curve: CP with the PH model. 
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Figure S2. Standardized net survival at 1 and 5 years as a function of the year of diagnosis in the five scenarios, with
2000 cases. Black solid curve: Theoretical standardized net survival; blue double-dashed curve: Mean of the standardized
net survival estimated using the Proportional Hazard model (PH); red dashed curve: Mean of the standardized net survival
estimated using the multidimensional penalized splines approach (MPS).
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Figure S3. Excess mortality hazard as a function of time since diagnosis in the five scenarios with 2000 cases, at 3 ages
(10th, 50th, and 90th percentiles of the age distribution of the cases). Solid curve: Theoretical excess mortality hazard; dashed
curve: Mean of the excess mortality hazard using themultidimensional penalized splines approach.
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Figure S4. Excess mortality hazard as a function of time since diagnosis in the five scenarios with 10000 cases, at 3 ages
(10th, 50th, and 90th percentiles of the age distribution of the cases). Solid curve: Theoretical excess mortality hazard; dashed
curve: Mean of the excess mortality hazard using themultidimensional penalized splines approach.
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Figure S5. Excess mortality hazard as a function of time since diagnosis in the five scenarios with 2000 cases, at 3 ages
(10th, 50th, and 90th percentiles of the age distribution of the cases). Solid curve: Theoretical excess mortality hazard; dashed
curve: Mean of the excess mortality hazard using the Proportional Hazard model.
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Figure S6. Excess mortality hazard as a function of time since diagnosis in the five scenarios with 10000 cases, at 3 ages
(10th, 50th, and 90th percentiles of the age distribution of the cases). Solid curve: Theoretical excess mortality hazard; dashed
curve: Mean of the excess mortality hazard using the Proportional Hazard model.
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Figure S7. Net survival at 1 and 5 years as a function of the year of diagnosis in the five scenarios with 2000 cases, at 3
ages (10th, 50th, and 90th percentiles of the age distribution of the cases). Solid curve: Theoretical age-specific net survival;
dashed curve: Mean of the age-specific net survival estimated using themultidimensional penalized splines approach.
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Figure S8. Net survival at 1 and 5 years as a function of the year of diagnosis in the five scenarios with 10000 cases, at 3
ages (10th, 50th, and 90th percentiles of the age distribution of the cases). Solid curve: Theoretical age-specific net survival;
dashed curve: Mean of the age-specific net survival estimated using themultidimensional penalized splines approach.
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Figure S9. Net survival at 1 and 5 years as a function of the year of diagnosis in the five scenarios with 2000 cases, at 3
ages (10th, 50th, and 90th percentiles of the age distribution of the cases). Solid curve: Theoretical age-specific net survival;
dashed curve: Mean of the age-specific net survival estimated using the Proportional Hazard model.
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Figure S10. Net survival at 1 and 5 years as a function of the year of diagnosis in the five scenarios with 10000 cases, at 3
ages (10th, 50th, and 90th percentiles of the age distribution of the cases). Solid curve: Theoretical age-specific net survival;
dashed curve: Mean of the age-specific net survival estimated using the Proportional Hazard model.
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Case study: trends in net survival and in the dynamics of excess
hazard from cervical cancer, in France.
This section is an illustration of a survival trends population-based study, as performed by the Multidimensional
Penalized Splines approach (MPS) and the Proportional Hazard model (PH).
Here, we studied trends in net survival (NS) and in the excess hazard for cervical cancer in France; this
study included all incident cases of primary invasive cervical cancer (ICD-03 code C53) diagnosed between
January 1, 1989 and December 31, 2010 in the area covered by 7 registries of the French Network of Cancer
registries (FRANCIM). The end of follow-up was June 30, 2013. This dataset was the one used to determine the
theoretical parameters in the cervix uteri scenario (see section 3 of the paper). It included 5977 cervical cancer
cases and 2139 (35.8%) deaths were observed within 5 years from diagnosis. Age at diagnosis ranged from 18
to 100 years (median: 49). More information about this dataset can be found in the works of Cowppli-bony and
al.1, 2
The MPS and PH approaches were identical to those described in the simulation study (see sections
2.3.3, 2.3.4 of the paper). The age-standardized NS for a given year of diagnosis was also calculated as in the
paper. We just recall that, for the MPS approach, the log-excess hazard was modelled as a function of time t,
age a, and year of diagnosis y using a tensor product smooth which basis was built using restricted cubic splines
of dimension 6, 5, and 4, respectively. The knot location of these splines was based on the empirical percentiles
observed in the population of patients who died. The smoothing parameters were estimated using the REML
criterion. For the PH approach, the excess hazard was modelled as
log(hE(t, a, y)) = ft(t) + fa(a) + fy(y),where
ft, fa, and fy were restricted cubic splines with the same features as the marginal bases of the MPS approach
(same number and location of the knots). The 13 parameters of this PH model were obtained using maximum
likelihood method (without any penalization).
We also replicated the analysis performed in Cowppli-bony and al,1, 2 which is very typical of what has been
done up-to-now in survival trends studies. In this study, NS was estimated using the non-parametric estimator
of Pohar-Perme3 (PP) and analysis was stratified by age-class (5 strata), and period of diagnosis (4 strata).
The resulting trends in age-standardized NS at 1 and 5 years are depicted in Figure S11. The MPS estimates
are reasonably concordant with the PP estimates, whereas an unobserved increase in standardized NS at 5 years
after year 2005 was obtained with the PH approach.
Figure S11. Standardized net survival at 1 and 5 years as a function of the year of diagnosis in Cervical cancer. Red solid
curve: Multidimensional Penalized Splines approach (MPS); blue dashed curve: Proportional Hazard model (PH); gray
segment: non-parametric estimation using the Pohar-Perme method with 95% CI (vertical bar).
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Figure S12. Net survival (NS) at 1 and 5 years as a function of the year of diagnosis in Cervical cancer, by age. The gray
segments correspond to the estimates by period and age-class obtained with the Pohar-Perme method with 95% CI (vertical
bar). Using the Multidimensional Penalized Splines approach (MPS; red solid curve) and the Proportional Hazard approach
(PH; blue dashed curve), NS was estimated at 5 ages, each age corresponding to the median of age within each of the 5
age-classes.
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Figure S12 shows the corresponding trends by age-class (PP) or at the median age determined within each class
(MPS and PH approaches). The MPS approach (red solid line) showed well distinct trends in survival at 1 and
5 years across ages, with an improvement observed in younger women and deterioration in older women. This
pattern was overall confirmed by the PP estimates, although variability of these estimates led to somewhat erratic
behaviors. As for the PH approach (blue dashed line), the pattern of trends in survival was inevitably similar
whatever the time and the age because of the constraints induced by this model: survival decreased between
years 1989 and circa 2004, then increased afterwards.
Figure S13 shows the dynamics of the excess hazard by age and year of diagnosis. The PH assumption and the
absence of interaction (dashed curves) can clearly be seen in this graph; for example, the resulting excess hazard
for y=2000 was higher than for y=1990 whatever the time and age. Conversely, the MPS approach provided a
more complex picture of the dynamics of the excess hazard, exhibiting strong time-age-year interactions. So the
dynamics were different according to age; excess hazard decreased regularly with time at older ages whereas
it peaked around 1.5 years from diagnosis at younger ages. Furthermore, excess hazard increased with year of
diagnosis for women aged 60 and over throughout the follow-up, while, in younger ages, it mainly decreased
with years of diagnosis (this led to the different NS trends according to age seen in figure S12).
Figure S13 thus provides fundamentals medical results and this kind of figure is indispensable for clinicians and
epidemiologists to help them understand the way medical practises have changed patient mortality over the year
of diagnosis.
Figure S13. Excess mortality hazard as a function of time since diagnosis in Cervical cancer, at 5 ages. Solid curve: excess
mortality hazard using the Multidimensional Penalized Splines approach; dashed curve: excess mortality hazard using the
Proportional Hazard model.
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In our view, this example in cervical cancer illustrates the advantages of an efficient modelling approach, such as
the MPS one, to study trends in survival and hazard. On one hand, both the degree of details and interpretation
of the results are limited with stratified analyses based on PP estimator. On the other hand, the PH approach
cannot describe properly the trends in survival or hazard whenever interactions are present. The MPS approach
is an appealing alternative to us, as it is able to catch complex trends, but still provides smooth estimates.
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The R-code to reproduce this analysis is available on the GitHub repository
https://github.com/RocheLHCL/SMMR_Remontet2018 (Cf. the readme.pdf for explanations of the
contents). However, due to copyright issues, we cannot provide the original real dataset. So, we provided one
of the simulated dataset used in the simulation study on cervix uteri cancer data on 10,000 patients. The results
may thus differ, to some extent, from those presented in the article.
References
1. Cowppli-Bony A, Uhry Z, Remontet L, et al. Survival of solid cancer patients in France, 1989-2013: a
population-based study. Eur J Cancer Prev. 2017; 26: 461-8.
2. Cowppli-Bony A, Uhry Z, Remontet L, et al. Survie des personnes atteintes de cancer en France
métropolitaine, 1989-2013. Partie 1 - Tumeurs solides. Saint-Maurice: Institut de veille sani-
taire, 2016. http://invs.santepubliquefrance.fr/fr../layout/set/print/Publications-et-outils/Rapports-et-
syntheses/Maladies-chroniques-et-traumatismes/2016/Survie-des-personnes-atteintes-de-cancer-en-
France-metropolitaine-1989-2013-Partie-1-tumeurs-solides
3. Perme MP, Stare J and Esteve J. On estimation in relative survival. Biometrics. 2012; 68: 113-20.
Page 16/16





